amino acids; magnesium chloride; potassium phosphate, dibasic; sodium chloride
Drug data last refreshed 1w ago · AI intelligence enriched 2w ago
AMINOSYN 8.5% W/ ELECTROLYTES is an injectable amino acid solution with essential electrolytes designed for parenteral nutrition support. It provides essential amino acids, magnesium, potassium, and sodium to patients unable to receive adequate nutrition orally or enterally. This is a nutritional support product, not a therapeutic agent with a defined mechanism of action.
Product approaching loss of exclusivity with low current competitive pressure (30/100), indicating a mature, stable market with limited growth opportunities for commercial teams.
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Working on AMINOSYN 8.5% offers stability and operational expertise but limited career growth in innovation or commercial expansion. Career advancement on this product is best suited for professionals focused on efficiency, cost management, and hospital/health system relationships rather than novel drug development.
Worked on AMINOSYN 8.5% W/ ELECTROLYTES at ICU Medical? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Upgrade to Pro to access CMS Part B ASP pricing data and other premium pharma intelligence.
Upgrade to Pro — $25/mo